The market simply has not understood how BIG this actually is.
PPL-1 is the first drug of its kind to be used in humans... it has previously been shown to increase the potency of other chemotherapeutic (anti-cancer) drugs by upto 100 times... and now they have shown in humans, that at its lowest dose, it has resulted in a reduction of upto 64% in certain tumour markers!
The implications of this are huge. Here we have a company that is potentially on the verge of proving up a drug which could on its own become an effective, safe and widely used cancer drug for MANY cancer types. In addition, it could be used in conjuction with existing chemotherapeutic agents in 1/100th of their current doses, potentially alleviating the devastating consequences of such drugs.
If this company, backed by Roger Aston, doesn't trade huge volume over 10c then i'll quite investing.
